The Complete Guide to GLP-1 Weight Loss Medications
GLP-1 receptor agonists have transformed medically-supervised weight management. This comprehensive guide covers the science, candidacy criteria, treatment timeline, and practical considerations for anyone exploring physician-guided GLP-1 therapy.
What Are GLP-1 Medications?
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications originally developed for type 2 diabetes that have demonstrated significant effects on appetite regulation and body weight. They mimic a natural hormone your body produces after eating, signaling fullness to the brain.
These medications work through multiple mechanisms: they slow gastric emptying so you feel full longer, reduce appetite signals in the hypothalamus, and improve insulin sensitivity. The result is a meaningful reduction in caloric intake without the constant hunger that derails most diets.
Compounded formulations of semaglutide and tirzepatide are prepared by state-licensed 503A and 503B pharmacies based on individual prescriptions. They are not FDA-approved products and are not generic versions of any branded medication.
Who Is a Candidate for GLP-1 Therapy?
GLP-1 medications are generally appropriate for adults with a BMI of 30 or above (obesity), or a BMI of 27 or above with at least one weight-related health condition such as hypertension, type 2 diabetes, or high cholesterol.
Your provider will evaluate your complete health history, current medications, and goals before determining if GLP-1 therapy is appropriate. Certain conditions — including a personal or family history of medullary thyroid carcinoma, pancreatitis, or pregnancy — may preclude use.
Not everyone who applies will qualify. The provider consultation exists specifically to ensure the medication is safe and appropriate for your individual situation.
The Treatment Timeline: What to Expect
Week 1-4: You begin at the lowest dose. Most patients notice reduced appetite within the first week. Mild gastrointestinal side effects (nausea, fullness) are common and typically resolve as your body adjusts.
Month 2-3: Your provider titrates the dose upward based on your response and tolerance. This is when most patients see meaningful changes in eating patterns and early weight trends.
Month 4-6: At maintenance dose, the medication's full effect on appetite and metabolism is established. Your provider monitors progress through regular check-ins and adjusts the plan as needed.
Ongoing: Treatment duration varies by individual. Some patients use GLP-1 medications for 12-18 months, others longer. Your provider will discuss a sustainable long-term plan including lifestyle factors that support lasting results.
Managing Side Effects
The most common side effects are gastrointestinal: nausea, constipation, and reduced appetite (which is partly the intended effect). These are typically mild to moderate and most pronounced during dose increases.
Practical strategies include eating smaller meals, avoiding greasy or very sweet foods, staying well-hydrated, and eating slowly. Most patients find side effects diminish significantly within 2-3 weeks at each dose level.
Serious side effects are rare but important to know: severe abdominal pain, persistent vomiting, or signs of pancreatitis warrant immediate medical attention. Your provider will review all safety information before prescribing.
How to Get Started
The process begins with a brief online health assessment — typically 10-15 minutes. You'll answer questions about your health history, current medications, weight goals, and any prior weight management attempts.
A licensed healthcare provider reviews your information and, if appropriate, prescribes a personalized treatment plan. Your medication is shipped directly from a licensed compounding pharmacy to your door.
Throughout treatment, you have ongoing access to your provider for dose adjustments, side effect management, and progress monitoring. The goal is sustainable, medically-supported weight management — not a quick fix.